Agenda
The Future of Chronic Care
On 28 February 2024, the HealthTechX Summit brought together an assembly of leading HealthTech entrepreneurs, investors, corporate digital health leaders, and policy makers to discuss the latest developments in the Future of Chronic Care.
Through a dynamic lineup of keynotes, fireside chats, and panel discussions, HealthTechX unveiled the latest trends and insights, showcasing technology's role in the management of chronic conditions - with the ultimate goal of improving patient outcomes.
Explore the 2024 agenda and speakers below or view our PDF programme here.
Confirmed Sessions
Beyond the Hype - AI’s Place in Healthcare
In a segment which relies heavily on doctor-patient relationships, AI offers true potential in how healthcare is delivered. How can developments in AI contribute to improved patient outcomes, efficiency of care delivery and better quality of life?
Confirmed speakers: Dr Hugh Harvey (Hadrian Health), Indra Joshi (Palantir Technologies), Pearse Keane (University College London), Paul Wicks (Wicks Digital Health)
The Evolution of Telehealth in a Post-COVID World
The rationale behind telehealth is to lower costs, improve efficiency and increase efficacy in healthcare delivery. Has the sector as a whole lived up to these expectations to provide a truly comprehensive patient experience at home. What innovations can we anticipate from the next generation of telehealth companies?
Confirmed speakers: Sokratis Papafloratos (Numan), Kalle Conneryd-Lundgren (Kry/Livi)
Hospital to Home - Enabling the Continuum of Care
In practice, most chronic conditions require ongoing care across clinical and home settings, but coordinating this care can be challenging for both patients and providers. How can technology bridge the gap to ensure a seamless transition between hospital stays and home-based care?
Confirmed speakers: Tauseef Mehrali (Ada Health)
From Prescription to Prevention - The Challenge of Lifestyle Change
Treating, preventing, and in some cases even reversing chronic conditions often involves recommending "lifestyle changes," a prescription that's simple to give but challenging for patients or even ostensibly healthy people to implement and maintain. How can technology be implemented to help patients and humanity at large make seemingly elusive lifestyle changes, to help them live as functionally as possible for as long as possible?
Confirmed speakers: Matthew Fenech (Una Health), Peter Ward (Humanity), Joe Stringer (Holland & Barrett, Letterone), Jay Shah (Aktiia)
Mental Health and Prevention
Mental health conditions are increasingly prevalent across global populations, and a mismatch exists between those who require care and those who are available to provide it. This panel will explore the technologies which exist to address this care gap and, importantly, to promote mental health in the population at large, to prevent the development of these conditions.
Confirmed speakers: Miranda Wolpert (Wellcome Trust), Heather Cook (Wellmind Health)
The Efficacy vs Access Axis
If one-to-one doctor-patient interactions are the most effective form of delivery, but technology driven care is the most accessible, how can the healthcare system create solutions for chronically ill patients which are both effective and widely accessible. Are there any true outliers on the axis?
Confirmed speakers: Vishaal Virani (YouTube UK and Ireland)
Cultural Competence in the Digital Age - Bridging Healthcare Inequities
Patients from different cultural, ethnic, and social backgrounds have unique healthcare needs and experiences. The potential of digital technologies in addressing these differences is undeniable, yet they also bring the risk of heightening exclusion among certain populations. How can technology companies bridge inequities in healthcare efficiently without amplifying the health divide further?
Confirmed speakers: Noel Gordon (Telstra Health), Maxine Mackintosh (Genomics England, One HealthTech), Ben Maruthappu (Cera Care), Dr Martin McShane (Optum)
Hearing from the Investors
Across all investment stages, how are top global investors approaching HealthTech investing in 2024? What makes an opportunity stand out?
Confirmed speakers: Pam Garside (Cambridge Angels), Michael Treskow (Eight Roads Ventures), Julien de Salaberry (Galen Growth)
From Data to Diagnosis: Improving Patient Care Pathways
Diagnostic accuracy plays a crucial role in the quality of long-term patient care; it determines the prospect of designing a tailored treatment plan that effectively addresses the patient's specific health issue. How can technology be harnessed to rapidly and efficiently transform clinical assessments into accurate diagnoses and tangible benefits for patients dealing with chronic diseases?
Confirmed speakers: Michelle Tempest (Candesic), Bjoern von Siemens (CareSyntax)
Strategies for Success - HealthTech in the NHS Landscape
For many digital health companies, understanding the direction of travel of the NHS and how to successfully engage and integrate with the healthcare system in the UK can be a challenge. How can healthtech businesses build a solid success story with the NHS, and facilitate access and scaling of innovative products and services for patients?
Confirmed speakers: Tamir Singer (NHSX), Konrad Dobschuetz (NHS Innovation Accelerator)
Plus more sessions and speakers coming soon!
2024 Agenda
*Agenda correct at time of publication. All sessions and speakers are subject to change.
Please feel free to contact us at hello@healthtechx.com if you have any questions.
2024 Advisory Board
Thank you to our esteemed Advisory Board members, who have kindly offered their expertise, insights and forward-thinking perspectives to help shape this year's agenda.
Paul Wicks
Paul Wicks, Ph.D., is an independent consultant who helps digital health companies generate evidence, revenue, and awareness. Prior to consulting, for 13 years he led innovation at PatientsLikeMe, an online community for over 850,000 people living with medical conditions.
Paul has over 180 peer-reviewed publications including multiple decentralised clinical trials, patient-reported outcomes, applications of medical AI, and a dose-response curve for friendship. He sits on the editorial boards of the BMJ, BMC Medicine, JMIR, Digital Biomarkers and The Patient.
Jessica Smith
Jessica is co-founder & CXO of SomX, a healthcare innovation communications agency. She is also an editor and regular host for Healthtech Pigeon, a news brand rounding up the sector's news. Previously an Associate Director at global agency, FleishmanHillard, Jessica has worked extensively across the healthcare ecosystem from the NHS, industry, Royal Colleges and charities, as well as in consumer health, healthtech, medical devices and pharmaceuticals.
Julien De Salaberry
Julien is the CEO and co-founder of Galen Growth, the world’s leading Digital Health private market data, intel and insights platform. He has over 30 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck & Co.
Julien has a deep understanding of organic and inorganic growth in healthcare in both mature and developing markets, addressing awareness, access and affordability challenges.
Julien co-authored iDirupted in 2014 and Living in the Age of the Jerk in 2020. Both books are focused on technology innovation and its impact on humans, our ecosystem and the economy.
Dr Michelle Tempest
Dr Michelle Tempest worked as a hospital doctor in the NHS for over a decade.
She is partner in a strategy consultancy company, Candesic, who deliver R&D level insight with CEO level clarity in specialist sectors – life sciences, healthcare, digital, medtech and education.
She edited a book called ‘The Future of the NHS’ and is the author of ‘Big Brain Revolution: Artificial Intelligence – Spy or Saviour’. She angel invests and mentors start-ups.